Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2013
Total Assets: $2.71B
Liabilities Breakdown FY2013
Total Liabilities: $1.17B
Asset Breakdown
Total Assets: $2.71B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $420.4M | 15.5% |
| Accounts Receivable | $302.5M | 11.2% |
| Inventory | $308.9M | 11.4% |
| Property, Plant & Equipment | $421.6M | 15.6% |
| Goodwill | $385.4M | 14.2% |
| Intangible Assets | $33.5M | 1.2% |
| Other Assets | $837.6M | 30.9% |
Liabilities Breakdown
Total Liabilities: $1.17B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $48.4M | 4.2% |
| Long-Term Debt | $593.1M | 50.9% |
| Other Liabilities | $524.0M | 45.0% |